COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,241 Articles (22,733 medRxiv, 8,508 bioRxiv)

Most recent first Previous |  Page 381: Articles 3801-3810  | Next

Cortical thickness alterations and systemic inflammation define long-COVID patients with cognitive impairment
Besteher, B., Rocktaeschel, T., Garza, A. P., Machnik, M., Ballez, J., Helbing, D. L., Finke, K., Reuken, P., Guellmar, D., Gaser, C., Walter, M., Opel, N., Dunay, I. R.
10.1101/2023.07.21.23292988 — Posted: 2023-07-23
Social Cohesion and Covid-19: an integrative review
Ware, P.
10.1101/2023.07.19.23292904 — Posted: 2023-07-23
Unraveling COVID-19 Relationship with Anxiety Disorders and Symptoms
Asgel, Z., Kouakou, M., Koller, D., Pathak, G. A., Cabrera-Mendoza, B., Polimanti, R.
10.1101/2023.07.21.23293001 — Posted: 2023-07-23
Several Mathematical Aspects on Daily Number of COVID-19 Infection Cases in Eight Southeast Asian Places
Chow, C. L., Cheng, C. H., Chow, W. K.
10.1101/2023.07.19.23292810 — Posted: 2023-07-23
Can computer simulation support strategic service planning? Modelling a large integrated mental health system on recovery from COVID-19
Pierotti, L. L., Cooper, J., James, C., Denholm, R., Cassels, K., Gara, E., Wood, R.
10.1101/2023.07.19.23292289 — Posted: 2023-07-23
Covid-19 related cognitive, structural and functional brain changes among Italian adolescents and young adults: a multimodal longitudinal case-control study
Invernizzi, A., Renzetti, S., van Thriel, C., Rechtman, E., Patrono, A., Ambrosi, C., Mascaro, L., Cagna, G., Gasparotti, R., Reichenberg, A., Tang, C. Y., Lucchini, R. G., Wright, R. O., Placidi, D., Horton, M.
10.1101/2023.07.19.23292909 — Posted: 2023-07-23
COVID-19 mitigation behaviors and policies limited SARS-CoV-2 transmission in the United States from September 2020 through November 2021
Lopez, V. K., Kada, S., Prasad, P. V., Chin, T., Cadwell, B. L., Healy, J. M., Slayton, R. B., Biggerstaff, M., Johansson, M. A.
10.1101/2023.07.19.23292882 — Posted: 2023-07-23
Mucosal and Systemic Immune Correlates of Viral Control following SARS-CoV-2 Infection Challenge in Seronegative Adults
Wagstaffe, H. R., Thwaites, R. S., Reynaldi, A., Sidhu, J. K., McKendry, R., Ascough, S., Papargyris, L., Collins, A. M., Xu, J., Lemm, N.-M., Siggins, M. K., Chain, B. M., Killingley, B., Kalinova, M., Mann, A., Catchpole, A., Davenport, M. P., Openshaw, P. J. M., Chiu, C.
10.1101/2023.07.21.23292994 — Posted: 2023-07-23
High seroprevalence after the second wave of SARS-COV2 respiratory infection in a small settlement in the northern coastal of Peru.
Toledo, A. K., Leon-Jimenez, F., Cavalcanti, S., Vilchez Barreto, P., Reto, N., Vega, J., Bolivar, L. M., Rhor, M., Ypanaque, J., Silva, H., Moyano, L. M., Group of Neuroepidemiology and Science of Life of Peru
10.1101/2023.07.19.23292491 — Posted: 2023-07-23
An engineered A549 cell line expressing CD13 and TMPRSS2 is permissive to clinical isolate of human coronavirus 229E
Lie, L. K., Synowiec, A., Mazur, J., Pyrc, K.
10.1101/2023.07.21.545505 — Posted: 2023-07-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).